Filing Details

Accession Number:
0001062993-12-001248
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-13 13:07:16
Reporting Period:
2010-04-01
Filing Date:
2012-04-13
Accepted Time:
2012-04-13 12:07:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098880 Intelgenx Technologies Corp. IGXT Pharmaceutical Preparations (2834) 870638336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1516366 Blumont Capital Corp 70 University Avenue, Suite 1200
Toronto A6 M5J 2M4
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-28 35,000 $0.43 4,859,300 No 4 P Direct
Common Stock Acquisiton 2011-02-28 60,000 $0.47 4,919,300 No 4 P Direct
Common Stock Disposition 2011-02-28 73,000 $0.52 4,846,300 No 4 S Direct
Common Stock Disposition 2011-03-02 100,000 $0.53 4,746,300 No 4 S Direct
Common Stock Acquisiton 2011-05-24 30,000 $0.60 4,776,300 No 4 P Direct
Common Stock Acquisiton 2011-06-15 60,000 $0.67 4,836,300 No 4 P Direct
Common Stock Acquisiton 2012-02-14 30,000 $0.59 4,866,300 No 4 P Direct
Common Stock Acquisiton 2012-03-19 125,000 $0.49 4,991,300 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 S Direct
No 4 S Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2010-08-27 225,000 $0.00 225,000 $0.50
Common Stock Warrant (Right to Buy) Acquisiton 2011-06-25 30,000 $0.00 30,000 $0.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
225,000 2010-08-27 2013-08-27 No 4 P Direct
255,000 2011-06-25 2014-06-25 No 4 P Direct